Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Pediatric Medicine

Rutgers Neuroscientist Finds a Way to Track and Measure Female Autism, Asperger’s

Dr. Elizabeth Torres

New Brunswick, NJ, September 13, 2017 — A Rutgers University study found that tracking and measuring the involuntary head movements revealed in functional magnetic resonance imaging (fMRI) scans offers a new, more accurate way to detect autism in girls.

Rutgers University-New Brunswick neuroscientist Elizabeth Torres, Ph.D., said the traditional criteria used to diagnose autism are largely based on the observed behavior of children, and since boys in western society are expected to be active, deviations from that norm are easy to spot.

Girls are socialized to be quieter, so autism is harder to observe. Perhaps partly due to these cultural biases, boys are diagnosed with autism five times as often as girls. “The criteria are male-driven, so we’re measuring females with a male ruler,” she said. Continue reading

I-ACT for Children Launches to Promote Innovative Medicines Development for Young Patients in Need

Washington, DC, April 19, 2017 — Lucy Vereshchagina reports on PhRMA’s Catalyst blog that, in an exciting step forward to support research and development of innovative new medicines and devices for pediatric patients, the Critical Path Institute (C-Path) announced the launch of a new nonprofit to address challenges in bringing new therapies to children in need.

Called the Institute for Advanced Clinical Trials for Children (I-ACT for Children), this new organization will seek to foster public-private collaboration in finding solutions to barriers to pediatric medicines development as well as improving the pediatric clinical trials process.

Specifically, it will work to optimize pediatric study designs, protocols, best practices, training and engagement of patients and parents to advance clinical trials to improve children’s health. Continue reading

New Report: Fewer U.S. Children Lack Access to Healthcare

doctor-kid-2Washington, DC, November 19, 2016 — As a growing number of U.S. children have gained health insurance over the past decade, fewer kids are missing out on things like physicals and dental exams, a recent study suggests.

Steep declines in the number of uninsured have been well documented, largely as a result of growth in Medicaid and the Children’s Health Insurance Program (CHIP).

But the current study offers fresh evidence that kids are not only getting insured — they’re also becoming more likely to receive the care they need. Continue reading